You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vandetanib, NSCLC, Maintenance, Phase II

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Physical Inactivity, Environmental Exposure, Mental Health Wellness 1 Trial (Schoolyard reconstruction)

Not yet recruiting
  • Physical Inactivity
  • +2 more
  • Schoolyard reconstruction
  • (no location specified)
May 9, 2023

CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

Recruiting
  • CAR-T Cell Therapy
  • GC012F injection
  • Shanghai, Shanghai, China
    Department of Rheumatology, Ren Ji Hospital South Campus, School
May 5, 2023

Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • Chronic Myelomonocytic Leukemia
  • LILRB4 STAR-T cells injection
  • Tianjin, Tianjin, China
  • +1 more
Feb 12, 2023

Patients With Myocardial Infarction

Not yet recruiting
  • To Investigate the Effect of CHIP on Renal Insufficiency in AMI Patients
  • No intervention
  • (no location specified)
Nov 27, 2023

Malocclusion, Class II Division 1 Malocclusion Trial in Hama (One-jaw mechanic total maxillary arch distalization, Two-jaw

Completed
  • Malocclusion
  • Class II Division 1 Malocclusion
  • One-jaw mechanic total maxillary arch distalization
  • +2 more
  • Hama, Hama City, Syrian Arab Republic
    Syrian Arab Republic -Department of Orhodontic, University of Ha
Aug 1, 2022

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital affiliated to Fudan University
Aug 12, 2022

Obesity Trial in Columbia (Vegan diet)

Completed
  • Obesity
  • Vegan diet
  • Columbia, South Carolina
    University of South Carolina
May 16, 2022

Circadian Rhythms and Sleep in Familial DSPS and ASPS

Recruiting
  • Circadian Rhythm Sleep Disorder
    • Chicago, Illinois
      Northwestern University
    Jan 23, 2023

    MDD Trial in Rockville (Psilocybin)

    Active, not recruiting
    • Major Depressive Disorder
    • Rockville, Maryland
      Maryland Oncology Hematology PA
    Oct 14, 2021

    Derived Parameters for Evaluating Fluid Accumulation

    Not yet recruiting
    • Critically Ill
    • Bio-electrical Impedance Analysis
    • (no location specified)
    Jul 26, 2023

    HIV Infection Trial in Worldwide (DTG +DRV/r, SOC)

    Completed
    • HIV Infection
    • Buenos Aires, Argentina
    • +30 more
    Mar 25, 2021

    Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

    Active, not recruiting
    Has Results
    • Small Lymphocytic Lymphoma
    • CLL (Chronic Lymphocytic Leukemia)
    • Fludarabine Phosphate
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 13, 2022

    Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

    Recruiting
    • Non-Hodgkin Lymphoma
    • +4 more
    • Duarte, California
    • +23 more
    Dec 28, 2022

    Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

    Terminated
    Has Results
    • Advanced Solid Tumors
    • Los Angeles, California
    • +29 more
    May 21, 2022

    RSV Infection Trial in Chengdu (XW001, Placebo)

    Recruiting
    • RSV Infection
    • Chengdu, Sichuan, China
      West China Second University Hospital, Sichuan University
    Mar 20, 2023

    Vulva Cancer, Vulva Tumor, Squamous Cell Cancer Trial (Pembrolizumab)

    Not yet recruiting
    • Vulva Cancer
    • +2 more
    • (no location specified)
    Mar 7, 2023

    Extensive-stage Small Cell Lung Cancer Trial in China (ZL-2306(nirapairb), Placebo)

    Terminated
    • Extensive-stage Small Cell Lung Cancer
    • Hefei, Anhui, China
    • +32 more
    Dec 16, 2020

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

    Not yet recruiting
    • HIV Infections
      • (no location specified)
      Jan 9, 2023

      Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

      Recruiting
      • Resectable Melanoma
      • +2 more
      • BCD-217
      • +3 more
      • Lesnoy, Belarus
      • +35 more
      Feb 21, 2023

      Cognition Disorders in Old Age, Lifestyle, Healthy, Diet, Healthy Trial (Healthy lifestyle)

      Not yet recruiting
      • Cognition Disorders in Old Age
      • +3 more
      • Healthy lifestyle
      • (no location specified)
      May 30, 2022

      COVID-19 Trial in Nanjing (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation, Recombinant Novel

      Recruiting
      • COVID-19
      • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
      • +3 more
      • Nanjing, Jiangsu, China
        Jiangsu Provincal Center for Disease Control and Prevention
      Jul 27, 2021

      Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)

      Recruiting
      • Endometrial Adenocarcinoma
      • Comparison of adjuvant therapies
      • Helsinki, Finland
        Helsinki University Hospital
      Dec 8, 2022

      HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

      Recruiting
      • HRD Cancer
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))

      Recruiting
      • Solid Tumors
      • Head and Neck Cancer
      • SYH2051 tablets
      • Intensity-Modulated Radiation Therapy (IMRT)
      • Shijiazhuang, Hebei, China
        Clinical Trials Information Group
      Aug 21, 2023